英语新闻 英语考试 留学英语 TEM英语 CET英语 BEC英语 托福英语 雅思英语 英语作文 英语故事 英语笑话 娱乐英语 行业英语 英语学习 生活英语
工作英语 奥运英语 法律英语 英语口语 英文阅读 写作翻译 词汇语法 专四八级 四级六级 考研英语 职称英语 疯狂英语 英文简历 奥运知识 名人演说
您现在的位置: 3edu教育网 >> 英语角 >> 英语新闻 >> 生活Life >> 正文    3edu教育网,百万资源,完全免费,无需注册,天天更新!

Concern widens over vaccines

Concern widens over vaccines

分类:生活Life   更新:2010/4/3   来源:网络

Concern widens over vaccines

    Public concern over quality control at a pharmaceutical company in East China's Jiangsu province has widened from the rabies vaccine to the H1N1 vaccine.
    The Hongkong-based Mingpao reported on Tuesday that the Ealong biotech company, located in Changzhou, used an "additive" when producing a rabies vaccine, which may affect more than 1 million people nationwide.
    The substance reportedly allows vaccines produced by the company to meet inspection standards at a lower cost, while compromising the drug's potency. The adulteration was allegedly used in more than half of its vaccine products in recent years.
    The Ealong biotech company admitted on Thursday that quality defects had been detected in four batches of rabies vaccine last December and that production had already been suspended.
    The company denied a media report that the rabies vaccine it produced in 2008 may affect more than 1 million Chinese people. It did not comment on the "additive" reportedly used in the vaccine.
    The investigation into the vaccine is ongoing, said Yan Jiangying, a spokeswoman for the State Food and Drug Administration, who refused to give any further information.
    Seven top executives from the company have reportedly been arrested on suspicion of producing and selling defective drugs, though local police authorities declined to confirm the arrests.
    The Ealong biotech company, which is controlled by the New York-listed Simcere Pharmaceutical Group, produced about 11 percent of the nation's rabies vaccines in 2008.
    The company is also one of eight domestic pharmaceutical manufacturers authorized to produce the H1N1 vaccine and reportedly produced 6.31 million doses of it last year.
    Up to now, no adverse reactions to the rabies vaccine have been reported, but a woman from Yancheng, Jiangsu province, has claimed there was a connection between her daughter's death one month ago and the H1N1 vaccine produced by the company, the Hunan-based Xiaoxiang Morning Post reported on Thursday.
    You Zhihua, 40, said her daughter was the victim of the H1N1 vaccine produced by the Ealong biotech company, reports said.
    You's daughter Fei Jingming, who was a high school student, was injected with the H1N1 vaccine on Nov 17, 2009.
    "Five days later, my child began to show symptoms of a cold and on Nov 23 she ran a fever. She didn't recover after receiving a transfusion and taking pills in the school's hospital. Meanwhile, I found some hemorrhage points on her legs and there were some blood blisters in her mouth," You was quoted as saying.
    On Dec 6, Fei's oral blood blisters became enlarged and her eyeballs started to bleed. Fei was soon sent to hospital and was diagnosed with acute aplastic anemia. On March 8, the girl died.
    You said local disease control authorities and the health bureau said the H1N1 vaccine would not lead to acute aplastic anemia, but You did not accept the result, reports said.
    The medical certification states that the H1N1 vaccine injected into Fei was produced by the Jiangsu Ealong biotech company, with the batch number 200909L13.
    Source: China Daily (By Wang Hongyi)

| 设为首页 | 加入收藏 | 联系我们 | 版权申明 | 隐私策略 | 关于我们 | 手机3edu | 返回顶部 |